RACK-1 overexpression protects against goniothalamin-induced cell death

S H Inayat-Hussain1, L T Wong, K M Chan

  • 1Toxicology and Biocompatibility Laboratory, Faculty of Allied Health Sciences, Universiti Kebangsaan Malaysia. salmaan@medic.ukm.my

Toxicology Letters
|August 25, 2009
PubMed

Insights

Goniothalamin induces cancer cell death, but overexpressing the receptor for activated protein C-kinase 1 (RACK-1) inhibits this effect. RACK-1 plays a key role in goniothalamin

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Death Signaling

Background:

  • Goniothalamin, a natural styryllactone, exhibits anticancer properties by inducing apoptosis.
  • Understanding the molecular mechanisms of goniothalamin-induced cytotoxicity is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To investigate the role of specific genes regulating apoptosis in T-cell lines in response to goniothalamin treatment.
  • To determine if modulating receptor for activated protein C-kinase 1 (RACK-1) expression affects goniothalamin-induced cell death.

Main Methods:

  • Stable transfection of T-cell lines (Jurkat and W7.2) with genes regulating apoptosis, including RACK-1 and rFau.
  • Assessment of goniothalamin-induced cytotoxicity using MTT and clonogenic assays.
  • Evaluation of DNA damage via Comet assay.

Main Results:

  • Overexpression of RACK-1 or pc3n3 (which upregulates RACK-1) inhibited goniothalamin-induced cell death in T-cells.
  • Overexpression of rFau did not confer resistance to goniothalamin.
  • Goniothalamin induced DNA strand breaks, an effect suppressed by RACK-1 overexpression.
  • Etoposide showed similar cytotoxicity across all cell lines, indicating specific effects of RACK-1 on goniothalamin response.

Conclusions:

  • Receptor for activated protein C-kinase 1 (RACK-1) plays a significant role in regulating the cell death signaling pathways triggered by goniothalamin.
  • Targeting RACK-1 may offer a strategy to modulate the efficacy of goniothalamin as an anticancer agent.